Ready to Use Pharmaceutical Packaging Market

Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market (3rd Edition): Distribution by Type of Container, Type of Closure, Material of Fabrication and Key Geographical Regions: Industry Trends and Global Forecasts, 2023 - 2035

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    121

  • Pages
    323

  • View Count
    29074

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Project Objectives
1.4. Scope of the Report
1.5. Inclusions and Exclusions
1.6. Key Questions Answered
1.7. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control

2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
2.7. Key Market Segmentations

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates

3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry

3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk

3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY
4.1 Chapter Overview

5. INTRODUCTION
5.1. Chapter Overview
5.2. Pharmaceutical Packaging and Filling
5.2.1. Need for Pharmaceutical Packaging
5.2.2. Types of Pharmaceutical Packaging
5.2.3. Limitations of Traditional Primary Packaging
5.2.4. Innovation in Pharmaceutical Packaging

5.3. Ready to Use Primary Packaging
5.3.1. Sterilization Techniques used in Primary Packaging
5.3.2. Advantages of Ready to Use Primary Packaging
5.3.3. Cost Saving Opportunities in Ready to Use Primary Packaging
5.3.4. Current Demand for Ready to Use Primary Packaging

5.4. Concluding Remarks

6. PRE-STERILIZED / READY TO USE CONTAINERS: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Pre-Sterilized / Ready to Use Containers: Overall Market Landscape
6.2.1. Analysis by Type of Container
6.2.2. Analysis by Material(s) of Fabrication
6.2.3. Analysis by Container Color
6.2.4. Analysis by Type of Compatible Drug(s)
6.2.5. Analysis by Scale of Operation
6.2.6. Analysis by Packaging Format(s)
6.2.7. Analysis by Sterilization Technique(s) Used
6.2.8. Analysis by Quality Certification(s) Obtained
6.2.9. Analysis by Target Market
6.2.10. Analysis by Availability of Additional Coating
6.2.11. Analysis by Availability of RTU Kits

6.3. Pre-Sterilized / Ready to Use Containers: Manufacturer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Leading Manufacturers: Analysis by Number of Products

7. PRE-STERILIZED / READY TO USE CLOSURES: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Pre-Sterilized / Ready to Use Closures: Overall Market Landscape
7.2.1. Analysis by Type of Closure
7.2.2. Analysis by Material(s) of Fabrication
7.2.3. Analysis by Type of Compatible Container(s)
7.2.4. Analysis by Type of Compatible Drug(s)
7.2.5. Analysis by Sterilization Technique(s) Used
7.2.6. Analysis by Available Finish Format(s)
7.2.7. Analysis by Quality Certification(s) Obtained
7.2.8. Analysis by Target Market
7.2.9. Analysis by Availability of Additional Coating

7.3. Pre-Sterilized / Ready to Use Closures: Manufacturer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Leading Manufacturers: Analysis by Number of Products

8. KEY INSIGHTS
8.1. Chapter Overview
8.2. Pre-Sterilized / Ready to Use Containers: Key Insights
8.2.1. Analysis by Type of Container and Scale of Operation
8.2.2. Analysis by Type of Container and Packaging Format(s)
8.2.3. Analysis by Type of Container and Material(s) of Fabrication
8.2.4. Analysis by Type of Container and Container Color
8.2.5. Analysis by Type of Container and Sterilization Technique(s) Used
8.2.6. Analysis by Type of Container and Type of Compatible Drug(s)
8.2.7. Analysis by Material(s) of Fabrication and Sterilization Technique(s) Used

8.3. Pre-Sterilized / Ready to Use Closures: Key Insights
8.3.1. Analysis by Type of Closure and Material(s) of Fabrication
8.3.2. Analysis by Type of Closure and Sterilization Technique(s) Used
8.3.3. Analysis by Type of Closure and Available Finish Format(s)
8.3.4. Analysis by Type of Closure and Type of Compatible Drug(s)

9. PRODUCT COMPETITIVENESS ANALYSIS: PRE-STERILIZED / READY TO USE CONTAINERS
9.1. Chapter Overview
9.2. Pre-Sterilized / Ready to Use Containers: Product Competitiveness Analysis
9.2.1. Assumptions and Key Parameters
9.2.2. Methodology
9.2.3. Product Competitiveness Analysis: Vials
9.2.4. Product Competitiveness Analysis: Syringes
9.2.5. Product Competitiveness Analysis: Bags
9.2.6. Product Competitiveness Analysis: Cartridges

10. PRODUCT COMPETITIVENESS ANALYSIS: PRE-STERILIZED / READY TO USE CLOSURES
10.1. Chapter Overview
10.2. Pre-Sterilized / Ready to Use Closures: Product Competitiveness Analysis
10.2.1. Assumptions and Key Parameters
10.2.2. Methodology
10.2.3. Product Competitiveness Analysis: Stoppers
10.2.4. Product Competitiveness Analysis: Plungers
10.2.5. Product Competitiveness Analysis: Caps
10.2.6. Product Competitiveness Analysis: Tip Caps / Needle Shields
10.2.7. Product Competitiveness Analysis: Seals

11. COMPANY PROFILES
11.1. Chapter Overview
11.2. APG Pharma Packaging
11.2.1. Company Overview
11.2.2. Product Portfolio
11.2.2.1. Ready to Use Closures

11.2.3. Recent Developments and Future Outlook

11.3. Aptar
11.3.1. Company Overview
11.3.2. Financial Information
11.3.3. Product Portfolio
11.3.3.1. Ready to Use Closures

11.3.4. Recent Developments and Future Outlook

11.4. Daikyo Seiko
11.4.1. Company Overview
11.4.2. Product Portfolio
11.4.2.1. Ready to Use Containers
11.4.2.2. Ready to Use Closures

11.4.3. Recent Developments and Future Outlook

11.5. Datwyler
11.5.1. Company Overview
11.5.2. Financial Information
11.5.3. Product Portfolio
11.5.3.1. Ready to Use Closures

11.5.4. Recent Developments and Future Outlook

11.6. DWK Life Sciences
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.2.1. Ready to Use Containers
11.6.2.2. Ready to Use Closures

11.6.3. Recent Developments and Future Outlook

11.7. Ningbo Zhengli Pharmaceutical Packaging
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.2.1. Ready to Use Containers

11.7.3. Recent Developments and Future Outlook

11.8. SCHOTT
11.8.1. Company Overview
11.8.2. Financial Information
11.8.3. Product Portfolio
11.8.3.1. Ready to Use Containers
11.8.3.2. Ready to Use Closures

11.8.4. Recent Developments and Future Outlook

11.9. Stevanato
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.2.1. Ready to Use Containers
11.9.2.2. Ready to Use Closures

11.9.3. Recent Developments and Future Outlook

11.10. West Pharmaceutical Services
11.10.1. Company Overview
11.10.2. Financial Information
11.10.3. Product Portfolio
11.10.3.1. Ready to Use Containers
11.10.3.2. Ready to Use Closures

11.10.4. Recent Developments and Future Outlook

12. PARTNERSHIPS AND COLLABORATIONS
12.1. Chapter Overview
12.2. Partnership Models
12.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Partnerships and Collaborations
12.3.1. Analysis by Year of Partnership
12.3.2. Analysis by Type of Partnership
12.3.3. Analysis by Year and Type of Partnership
12.3.4. Analysis by Type of Partner
12.3.5. Analysis by Year of Partnership and Type of Partner
12.3.6. Analysis by Type of Partnership and Type of Partner
12.3.7. Analysis by Purpose of Partnership
12.3.8. Analysis by Type of Packaging System
12.3.9. Analysis by Type of Packaging Material
12.3.10. Most Active Players: Analysis by Number of Partnerships

12.3.11. Analysis by Geography
12.3.11.1. Intercontinental and Intracontinental Deals

13. MARKET ENTRY DECISION MAKING FRAMEWORK
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Key Parameters Impacting Market Entry Decision Making
13.3.1. Product Reach
13.3.2. Product Differentiation
13.3.3. Market Activity
13.3.4. Product Competitiveness
13.3.5. Manufacturing Complexity

13.4. Concluding Remarks

14. DEMAND ANALYSIS
14.1. Chapter Overview
14.2. Scope and Methodology
14.3. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Type of Container
14.3.1. Pre-Sterilized / Ready to Use Vials, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.2. Pre-Sterilized / Ready to Use Syringes, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.3. Pre-Sterilized / Ready to Use Cartridges, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

14.4. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Type of Closure
14.4.1. Pre-Sterilized / Ready to Use Caps, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4.2. Pre-Sterilized / Ready to Use Plungers, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4.3. Pre-Sterilized / Ready to Use Seals, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4.4. Pre-Sterilized / Ready to Use Stoppers, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4.5. Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

14.5. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Material of Fabrication
14.5.1. Pre-Sterilized / Ready to Use Aluminum Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.5.2. Pre-Sterilized / Ready to Use Glass Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.5.3. Pre-Sterilized / Ready to Use Plastic Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.5.4. Pre-Sterilized / Ready to Use Rubber Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

14.6. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Key Geographical Region
14.6.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.6.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.6.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.6.4. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.6.5. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.6.6. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

15. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
15.1. Chapter Overview
15.2. Market Drivers
15.3. Market Restraints
15.4. Market Opportunities
15.5. Market Challenges
15.6. Conclusion

16. GLOBAL PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET
16.1. Chapter Overview
16.2. Assumptions and Methodology
16.3. Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.1. Scenario Analysis
16.3.1.1. Conservative Scenario
16.3.1.2. Optimistic Scenario

16.4. Key Market Segmentations
16.5. Dynamic Dashboard

17. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY TYPE OF CONTAINER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Pre-Sterilized / Ready to use Pharmaceutical Packaging Market: Distribution by Type of Container, 2018, 2023 and 2035
17.3.1. Vials: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.2. Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.3. Cartridges: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

17.4. Data Triangulation and Validation

18. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY TYPE OF CLOSURE
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Distribution by Type of Closure, 2018, 2023 and 2035
18.3.1. Caps: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.2 Plungers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.3. Seals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.4. Stoppers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.5. Tip Caps / Needle Shields: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

18.4. Data Triangulation and Validation

19. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL OF FABRICATION
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Aluminum Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.4. Glass Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.5. Plastic Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.6. Rubber Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.7. Data Triangulation and Validation

20. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY KEY GEOGRAPHICAL REGION
20.1. Chapter Overview
20.2. Key Assumptions and Methodology

20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.3.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures

20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.4.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures

20.5. Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.5.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures

20.6. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.6.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.6.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures

20.7. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.7.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures

20.8. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.8.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.8.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures

20.9. Data Triangulation and Validation

21. EMERGING TRENDS IN PHARMACEUTICAL PACKAGING
21.1. Chapter Overview
21.2. Emerging Trends
21.2.1. Preference for Self-Medication of Drugs, Through the Use of Modern Drug Delivery Devices
21.2.2. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
21.2.3. Availability of Modular Facilities
21.2.4. Growing Demand and Preference for Personalized Therapies
21.2.5. Rise in Provisions for Automating Fill / Finish Operations
21.2.6. Surge in Partnership Activity
21.2.7. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions

21.3. Concluding Remarks

22. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING
22.1. Chapter Overview
22.2. Role of Robotics in Pharmaceutical Industry
22.2.1. Key Considerations for Selecting a Robotic System
22.2.2. Advantages of Robotic Systems
22.2.3. Disadvantages of Robotic Systems

22.3. Companies Providing Robots for Use in Pharmaceutical Industry

22.4. Companies Providing Equipment Integrated Robotic Systems in Pharmaceutical Packaging
22.4.1. Aseptic Technologies
22.4.1.1. Crystal L1 Robot Line
22.4.1.2. Crystal SL1 Robot Line

22.4.2. AST
22.4.2.1. ASEPTiCELL
22.4.2.2. GENiSYS R
22.3.2.3. GENiSYS C
22.3.2.4. GENiSYS Lab

22.4.3. Bosch Packaging Technology
22.4.3.1. ATO

22.4.4. Dara Pharma
22.4.4.1. SYX-E Cartridge + RABS

22.4.5. Fedegari
22.4.5.1. Fedegari Isolator

22.4.6. IMA
22.4.6.1. INJECTA
22.4.6.2. STERI LIF3

22.4.7. Steriline
22.4.7.1. Robotic Nest Filling Machine (RNFM)
22.4.7.2. Robotic Vial Filling Machine (RVFM)
22.4.7.3. Robotic Vial Capping Machine (RVCM)

22.4.8. Vanrx Pharmasystems
22.4.8.1. Microcell Vial Filler
22.4.8.2. SA25 Aseptic Filling Workcell

22.5. Concluding Remarks

23. CONCLUSION
23.1. Chapter Overview

24. EXECUTIVE INSIGHTS
24.1. Chapter Overview
24.2. Jinan Youlyy Industrial
24.2.1. Company Snapshot
24.2.2. Interview Transcript: Cara Qiu, Business Development Specialist

24.3. Sagar Rubber
24.3.1. Company Snapshot
24.3.2. Interview Transcript: Daxesh Shah, Founder and Managing Director

24.4. Aseptic Technologies
24.4.1. Company Snapshot
24.4.2. Interview Transcript: Julien Maréchal, Business Development and Technology Director

24.5. BioPhorum Operations
24.5.1. Company Snapshot
24.5.2. Interview Transcript: Malcolm Gilmore, Former Facilitator

24.6. PYRAMID Laboratories
24.6.1. Company Snapshot
24.6.2. Interview Transcript: Konstantin Kazarian, Former Project Manager of Business Development

25. APPENDIX 1: TABULATED DATA

26. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION

List Of Figures

Figure 2.1 Research Methodology: Research Methodology
Figure 2.2 Research Methodology: Forecast Methodology
Figure 2.3 Research Methodology: Robust Quality Control
Figure 2.4 Research Methodology: Key Market Segmentation
Figure 4.1 Executive Summary: Pre-Sterilized / Ready to Use Containers Market Landscape
Figure 4.2 Executive Summary: Pre-Sterilized / Ready to Use Closures Market Landscape
Figure 4.3 Executive Summary: Partnerships and Collaborations
Figure 4.4 Executive Summary: Market Entry Decision Making Framework
Figure 4.5 Executive Summary: Demand Analysis
Figure 4.6 Executive Summary: Market Sizing and Opportunity Analysis
Figure 5.1 Advantages of Pharmaceutical Packaging
Figure 5.2 Type of Pharmaceutical Packaging
Figure 5.3 Innovation in Pharmaceutical Packaging and Value Chain
Figure 5.4 Ready to Use Enables Flexible, Flexible Aseptic Processing
Figure 5.5 Advantages of Ready to Use Platform
Figure 5.6 Drivers of Ready to Use Platform
Figure 6.1 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Container
Figure 6.2 Pre-Sterilized / Ready to Use Containers: Distribution by Material(s) of Fabrication
Figure 6.3 Pre-Sterilized / Ready to Use Containers: Distribution by Container Color
Figure 6.4 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Compatible Drug(s)
Figure 6.5 Pre-Sterilized / Ready to Use Containers: Distribution by Scale of Operation
Figure 6.6 Pre-Sterilized / Ready to Use Containers: Distribution by Packaging Format(s)
Figure 6.7 Pre-Sterilized / Ready to Use Containers: Distribution by Sterilization Technique(s) Used
Figure 6.8 Pre-Sterilized / Ready to Use Containers: Distribution by Quality Certification(s) Obtained
Figure 6.9 Pre-Sterilized / Ready to Use Containers: Distribution by Target Market
Figure 6.10 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of Additional Coating
Figure 6.11 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of RTU Kits
Figure 6.12 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Year of Establishment
Figure 6.13 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Company Size
Figure 6.14 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 6.15 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 6.16 Leading Manufacturers: Distribution by Number of Products
Figure 7.1 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Closure
Figure 7.2 Pre-Sterilized / Ready to Use Closures: Distribution by Material(s) of Fabrication
Figure 7.3 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Container(s)
Figure 7.4 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Drug(s)
Figure 7.5 Pre-Sterilized / Ready to Use Closures: Distribution by Sterilization Technique(s) Used
Figure 7.6 Pre-Sterilized / Ready to Use Closures: Distribution by Available Finish Format(s)
Figure 7.7 Pre-Sterilized / Ready to Use Closures: Distribution by Quality Certification(s) Obtained
Figure 7.8 Pre-Sterilized / Ready to Use Closures: Distribution by Target Market
Figure 7.9 Pre-Sterilized / Ready to Use Closures: Distribution by Availability of Additional Coating
Figure 7.10 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Year of Establishment
Figure 7.11 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Company Size
Figure 7.12 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 7.13 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 7.14 Leading Manufacturers: Distribution by Number of Products
Figure 8.1 Key Insights: Distribution by Type of Container and Scale of Operation
Figure 8.2 Key Insights: Distribution by Type of Container and Packaging Format(s)
Figure 8.3 Key Insights: Distribution by Type of Container and Material(s) of Fabrication
Figure 8.4 Key Insights: Distribution by Type of Container and Container Color
Figure 8.5 Key Insights: Distribution by Type of Container and Sterilization Technique(s) Used
Figure 8.6 Key Insights: Distribution by Type of Container and Type of Compatible Drug(s)
Figure 8.7 Key Insights: Distribution by Material(s) of Fabrication and Sterilization Technique(s) Used
Figure 8.8 Key Insights: Distribution by Type of Closure and Material(s) of Fabrication
Figure 8.9 Key Insights: Distribution by Type of Closure and Sterilization Technique(s) Used
Figure 8.10 Key Insights: Distribution by Type of Closure and Available Finish Format(s)
Figure 8.11 Key Insights: Distribution by Type of Closure and Type of Compatible Drug(s)
Figure 9.1 Product Competitiveness Analysis: Vials
Figure 9.2 Product Competitiveness Analysis: Syringes
Figure 9.3 Product Competitiveness Analysis: Bags
Figure 9.4 Product Competitiveness Analysis: Cartridges
Figure 10.1 Product Competitiveness Analysis: Stoppers
Figure 10.2 Product Competitiveness Analysis: Plungers
Figure 10.3 Product Competitiveness Analysis: Caps
Figure 10.4 Product Competitiveness Analysis: Tip Caps / Needle Shields
Figure 10.5 Product Competitiveness Analysis: Seals
Figure 11.1 Aptar: Annual Revenues, 2016-Q1 2023 (USD Billion)
Figure 11.2 Datwyler: Annual Revenues, 2016-2022 (CHF Billion)
Figure 11.3 SCHOTT: Annual Revenues, FY 2019-FY 2022 (EUR Billion)
Figure 11.4 West Pharmaceutical Services: Annual Revenues, 2018-2022 (USD Billion)
Figure 12.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2023
Figure 12.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 12.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 12.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 12.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2015-2023
Figure 12.6 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 12.7 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 12.8 Partnerships and Collaborations: Distribution by Type of Packaging System
Figure 12.9 Partnerships and Collaborations: Distribution by Type of Packaging Material
Figure 12.10 Most Active Players: Distribution by Number of Partnerships
Figure 12.11 Partnerships and Collaborations: Local and International Agreements
Figure 12.12 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 13.1 Spider Web Analysis: Product Reach
Figure 13.2 Spider Web Analysis: Product Differentiation
Figure 13.3 Spider Web Analysis: Market Activity
Figure 13.4 Spider Web Analysis: Product Competitiveness
Figure 13.5 Spider Web Analysis: Manufacturing Complexity
Figure 13.6 Market Entry Decision Making Framework: Concluding Remarks
Figure 14.1 Demand for Pre-Sterilized / Ready to Use Vials, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.2 Demand for Pre-Sterilized / Ready to Use Syringes, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.3 Demand for Pre-Sterilized / Ready to Use Cartridges, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.4 Demand for Pre-Sterilized / Ready to Use Caps, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.5 Demand for Pre-Sterilized / Ready to Use Plungers, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.6 Demand for Pre-Sterilized / Ready to Use Seals, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.7 Demand for Pre-Sterilized / Ready to Use Stoppers, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.8 Demand for Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.9 Demand for Pre-Sterilized / Ready to Use Aluminum Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.10 Demand for Pre-Sterilized / Ready to Use Glass Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.11 Demand for Pre-Sterilized / Ready to Use Plastic Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.12 Demand for Pre-Sterilized / Ready to Use Rubber Containers and Closures, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.13 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.14 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.15 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.16 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.17 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 14.18 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 16.1 Percentage Distribution of Production and Processing Costs for Primary Packaging Components
Figure 16.2 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 16.3 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Conservative Scenario
Figure 16.4 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Optimistic Scenario
Figure 16.5 Dynamic Dashboard
Figure 17.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Distribution by Type of Container, 2018, 2023 and 2035 (USD Billion)
Figure 17.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Vials: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 17.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 17.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Cartridges: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 18.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Distribution by Type of Closure, 2018, 2023 and 2035 (USD Billion)
Figure 18.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Caps: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 18.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plungers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 18.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Seals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 18.5 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Stoppers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 18.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Tip Caps / Needle Shields: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Aluminum Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 19.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Glass Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 19.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plastic Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 19.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Rubber Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.5 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.7 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.8 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.9 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.10 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.11 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.12 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.13 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.14 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.15 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.17 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.18 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 21.1 Emerging Trends in Pharmaceutical Packaging
Figure 21.2 Future Growth Opportunities for Ready to Use Containers and Closures Based on Recent Trends
Figure 22.1 Key Considerations for Selecting a Robotic System
Figure 22.2 Pharmaceutical Manufacturing: Advantages of Robotic Systems
Figure 22.3 Pharmaceutical Manufacturing: Disadvantages of Robotic Systems
Figure 23.1 Concluding Remarks: Pre-Sterilized / Ready to Use Containers Market Landscape
Figure 23.2 Concluding Remarks: Pre-Sterilized / Ready to Use Closures Market Landscape
Figure 23.3 Concluding Remarks: Partnerships and Collaborations
Figure 23.4 Concluding Remarks: Market Entry Decision Making Framework
Figure 23.5 Concluding Remarks: Demand Analysis
Figure 23.6 Concluding Remarks: Market Forecast

List Of Tables

Table 5.1 Compatibility of Polymers with Ethylene Oxide Sterilization
Table 5.2 Advantages and Disadvantages of Different Sterilization Techniques
Table 6.1 Pre-Sterilized / Ready to Use Containers: Information on Type of Container, Material(s) of Fabrication, Container Color and Type of Compatible Drug(s)
Table 6.2 Pre-Sterilized / Ready to Use Containers: Information on Scale of Operation, Packaging Format(s) and Sterilization Technique(s) Used
Table 6.3 Pre-Sterilized / Ready to Use Containers: Information on Quality Certification(s) Obtained and Target Market
Table 6.4 Pre-Sterilized / Ready to Use Containers: Information on Availability of Additional Coating and RTU Kits
Table 6.5 Pre-Sterilized / Ready to Use Containers: List of Manufacturers
Table 7.1 Pre-Sterilized / Ready to Use Closures: Information on Type of Closure, Material(s) of Fabrication, Type of Compatible Container(s), Type of Compatible Drug(s) and Sterilization Technique(s) Used
Table 7.2 Pre-Sterilized / Ready to Use Closures: Information on Available Finish Format(s), Quality Certification(s) Obtained and Target Market
Table 7.3 Pre-Sterilized / Ready to Use Closures: Information on Availability of Additional Coating
Table 7.4 Pre-Sterilized / Ready to Use Closures: List of Manufacturers
Table 11.1 Leading Ready to Use Container and Closure Manufacturers
Table 11.2 APG Pharma Packaging: Company Snapshot
Table 11.3 APG Pharma Packaging: Ready to Use Closures
Table 11.4 Aptar: Company Snapshot
Table 11.5 Aptar: Ready to Use Closures
Table 11.6 Aptar: Recent Developments and Future Outlook
Table 11.7 Daikyo Seiko: Company Snapshot
Table 11.8 Daikyo Seiko: Ready to Use Containers
Table 11.9 Daikyo Seiko: Ready to Use Closures
Table 11.10 Datwyler: Company Snapshot
Table 11.11 Datwyler: Ready to Use Closures
Table 11.12 Datwyler: Recent Developments and Future Outlook
Table 11.13 DWK Life Sciences: Company Snapshot
Table 11.14 DWK Life Sciences: Ready to Use Containers
Table 11.15 DWK Life Sciences: Ready to Use Closures
Table 11.16 DWK Life Sciences: Recent Developments and Future Outlook
Table 11.17 Ningbo Zhengli Pharmaceutical Packaging: Company Snapshot
Table 11.18 Ningbo Zhengli Pharmaceutical Packaging: Ready to Use Containers
Table 11.19 Ningbo Zhengli Pharmaceutical Packaging: Recent Developments and Future Outlook
Table 11.20 SCHOTT: Company Snapshot
Table 11.21 SCHOTT: Ready to Use Containers
Table 11.22 SCHOTT: Ready to Use Closures
Table 11.23 SCHOTT: Recent Developments and Future Outlook
Table 11.24 Stevanato: Company Snapshot
Table 11.25 Stevanato: Ready to Use Containers
Table 11.26 Stevanato: Ready to Use Closures
Table 11.27 Stevanato: Recent Developments and Future Outlook
Table 11.28 West Pharmaceutical Services: Company Snapshot
Table 11.29 West Pharmaceutical Services: Ready to Use Containers
Table 11.30 West Pharmaceutical Services: Ready to Use Closures
Table 11.31 West Pharmaceutical Services: Recent Developments and Future Outlook
Table 12.1 Pre-Sterilized / Ready to Use Containers and Closures: List of Partnerships and Collaborations, 2015-2023
Table 14.1 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Type of Container
Table 14.2 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Type of Closure
Table 14.3 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Material of Fabrication
Table 14.4 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023 and 2035: Distribution by Key Geographical Regions
Table 16.1 Tiered Pricing Structure for Pre-Sterilized / RTU Pharmaceutical Packaging across Different Geographies
Table 22.1 List of Pharmaceutical Robotics Manufacturers
Table 22.2 Aseptic Technologies: Company Overview
Table 22.3 Aseptic Technologies: Key Specifications of Crystal L1 Robot Line
Table 22.4 Aseptic Technologies: Key Specifications of Crystal SL1 Robot Line
Table 22.5 AST: Company Overview
Table 22.6 AST: Key Specifications of ASEPTiCell
Table 22.7 AST: Key Specifications of GENiSYS R
Table 22.8 AST: Key Specifications of GENiSYS C
Table 22.9 AST: Key Specifications of GENiSYS Lab
Table 22.10 Bosch Packaging Technology: Company Overview
Table 22.11 Bosch Packaging Technology: Key Specifications of ATO
Table 22.12 Dara Pharma: Company Overview
Table 22.13 Dara Pharma: Key Specifications of SYX-E Cartridge + RABS
Table 22.14 Fedegari: Company Overview
Table 22.15 Fedegari: Key Specifications of Fedegari Isolator
Table 22.16 IMA: Company Overview
Table 22.17 IMA: Key Specifications of INJECTA
Table 22.18 IMA: Key Specifications of STERI LIF3
Table 22.19 Steriline: Company Overview
Table 22.20 Steriline: Key Specifications of Robotic Nest Filling Machine
Table 22.21 Steriline: Key Specifications of Robotic Vial Filling Machine
Table 22.22 Steriline: Key Specifications of Robotic Vial Capping Machine)
Table 22.23 Vanrx Pharmasystems: Company Overview
Table 22.24 Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 22.25 Key Specifications of SA25 Aseptic Filling Workcell
Table 24.1 Jinan Youlyy Industrial: Company Snapshot
Table 24.2 Sagar Rubber: Company Snapshot
Table 24.3 Aseptic Technologies: Company Snapshot
Table 24.4 BioPhorum Operations: Company Snapshot
Table 24.5 PYRAMID Laboratories: Company Snapshot
Table 25.1 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Container
Table 25.2 Pre-Sterilized / Ready to Use Containers: Distribution by Material(s) of Fabrication
Table 25.3 Pre-Sterilized / Ready to Use Containers: Distribution by Container Color
Table 25.4 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Compatible Drug(s)
Table 25.5 Pre-Sterilized / Ready to Use Containers: Distribution by Scale of Operation
Table 25.6 Pre-Sterilized / Ready to Use Containers: Distribution by Packaging Format(s)
Table 25.7 Pre-Sterilized / Ready to Use Containers: Distribution by Sterilization Technique(s) Used
Table 25.8 Pre-Sterilized / Ready to Use Containers: Distribution by Quality Certification(s) Obtained
Table 25.9 Pre-Sterilized / Ready to Use Containers: Distribution by Target Market
Table 25.10 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of Additional Coating
Table 25.11 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of RTU Kits
Table 25.12 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Year of Establishment
Table 25.13 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Company Size
Table 25.14 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 25.15 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 25.16 Leading Manufacturers: Distribution by Number of Products
Table 25.17 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Closure
Table 25.18 Pre-Sterilized / Ready to Use Closures: Distribution by Material(s) of Fabrication
Table 25.19 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Container(s)
Table 25.20 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Drug(s)
Table 25.21 Pre-Sterilized / Ready to Use Closures: Distribution by Sterilization Technique(s) Used
Table 25.22 Pre-Sterilized / Ready to Use Closures: Distribution by Available Finish Format(s)
Table 25.23 Pre-Sterilized / Ready to Use Closures: Distribution by Quality Certification(s) Obtained
Table 25.24 Pre-Sterilized / Ready to Use Closures: Distribution by Target Market
Table 25.25 Pre-Sterilized / Ready to Use Closures: Distribution by Availability of Additional Coating
Table 25.26 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Year of Establishment
Table 25.27 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Company Size
Table 25.28 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 25.29 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 25.30 Leading Manufacturers: Distribution by Number of Products
Table 25.31 Key Insights: Distribution by Type of Container and Scale of Operation
Table 25.32 Key Insights: Distribution by Type of Container and Packaging Format(s)
Table 25.33 Key Insights: Distribution by Type of Container and Material(s) of Fabrication
Table 25.34 Key Insights: Distribution by Type of Container and Container Color
Table 25.35 Key Insights: Distribution by Type of Container and Sterilization Technique(s) Used
Table 25.36 Key Insights: Distribution by Type of Container and Type of Compatible Drug(s)
Table 25.37 Key Insights: Distribution by Material(s) of Fabrication and Sterilization Technique(s) Used
Table 25.38 Key Insights: Distribution by Type of Closure and Material(s) of Fabrication
Table 25.39 Key Insights: Distribution by Type of Closure and Sterilization Technique(s) Used
Table 25.40 Key Insights: Distribution by Type of Closure and Available Finish Format(s)
Table 25.41 Key Insights: Distribution by Type of Closure and Type of Compatible Drug(s)
Table 25.42 Aptar: Annual Revenues, 2016-Q1 2023 (USD Billion)
Table 25.43 Datwyler: Annual Revenues, 2016-2022 (CHF Billion)
Table 25.44 SCHOTT: Annual Revenues, FY 2019-FY 2022 (EUR Billion)
Table 25.45 West Pharmaceutical Services: Annual Revenues, 2018-2022 (USD Billion)
Table 25.46 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2023
Table 25.47 Partnerships and Collaborations: Distribution by Type of Partnership
Table 25.48 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 25.49 Partnerships and Collaborations: Distribution by Type of Partner
Table 25.50 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2015-2023
Table 25.51 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 25.52 Partnerships and Collaborations: Distribution by Purpose(s) of Partnership
Table 25.53 Partnerships and Collaborations: Distribution by Type of Packaging System
Table 25.54 Partnerships and Collaborations: Distribution by Type of Packaging Material
Table 25.55 Most Active Players: Distribution by Number of Partnerships
Table 25.56 Partnerships and Collaborations: Local and International Agreements
Table 25.57 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 25.58 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Container
Table 25.59 Demand for Pre-Sterilized / Ready to Use Vials, 2023-2035
Table 25.60 Demand for Pre-Sterilized / Ready to Use Syringes, 2023-2035
Table 25.61 Demand for Pre-Sterilized / Ready to Use Cartridges, 2023-2035
Table 25.62 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Closure
Table 25.63 Demand for Pre-Sterilized / Ready to Use Caps, 2023-2035
Table 25.64 Demand for Pre-Sterilized / Ready to Use Plungers, 2023-2035
Table 25.65 Demand for Pre-Sterilized / Ready to Use Seals, 2023-2035
Table 25.66 Demand for Pre-Sterilized / Ready to Use Stoppers, 2023-2035
Table 25.67 Demand for Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, 2023-2035
Table 25.68 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Material of Fabrication
Table 25.69 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Aluminum Containers and Closures, 2023-2035
Table 25.70 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Glass Containers and Closures, 2023-2035
Table 25.71 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Plastic Containers and Closures, 2023-2035
Table 25.72 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Rubber Containers and Closures, 2023-2035
Table 25.73 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Geography
Table 25.74 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, 2023-2035
Table 25.75 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, 2023-2035
Table 25.76 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, 2023-2035
Table 25.77 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, 2023-2035
Table 25.78 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, 2023-2035
Table 25.79 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, 2023-2035
Table 25.80 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.81 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Optimistic Scenario
Table 25.82 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Conservative Scenario
Table 25.83 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Vials: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.84 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.85 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Cartridges: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.86 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Caps: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.87 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plungers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.88 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Seals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.89 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Stoppers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.90 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Tip Caps / Needle Shields: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.91 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Aluminum Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.92 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Glass Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (20232035)
Table 25.93 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plastic Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.94 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Rubber Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.95 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.96 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.97 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.98 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.99 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.100 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.101 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.102 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.103 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.104 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.105 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.106 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.107 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.108 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.109 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.110 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.111 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.112 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report:

  1. Aseptic Technologies
  2. Asea Brown Boveri (ABB)
  3. Afton Scientific
  4. ALK Life Science Solutions
  5. Allergy Laboratories
  6. Eurofins Amatsigroup
  7. Anhui Huaxin Pharmaceutical Glass Products
  8. APG Pharma
  9. Aptar
  10. ARaymond Life
  11. Automated Systems of Tacoma (AST)
  12. Balda
  13. Becton, Dickinson, and Company (BD)
  14. Berkshire Sterile Manufacturing
  15. Bharat Rubber Works
  16. Bhasin Packwell
  17. Biomedical Advanced Research and Development Authority (BARDA)
  18. Bormioli Pharma
  19. Bosch Packaging Technology
  20. CellBios Healthcare and Lifesciences
  21. Centor
  22. Charter Medical
  23. China Lemon Trading
  24. Coalition for Epidemic Preparedness Innovations (CEPI)
  25. Colanar
  26. Corning
  27. Credence MedSystems
  28. CSP Technologies
  29. Daikyo Seiko
  30. Dara Pharma
  31. Datwyler
  32. DENSO
  33. D. Lab Solutions
  34. DWK Life Sciences
  35. EMA Pharmaceuticals
  36. Entegris
  37. FANUC America
  38. Fedegari
  39. Flexan
  40. GCL Pharma
  41. Gerresheimer
  42.  Government of Canada
  43.  Helapet
  44.  Huayi Isotopes Company (HIC)
  45.  ILC Dover
  46.  ISOLAB
  47. Jiangsu Hualan New Pharmaceutical Material
  48. Jinan Youlyy Industrial
  49. Kawasaki Heavy Industries
  50. Kimble Chase
  51. KISHORE GROUP
  52. Klenzaids
  53. KUKA
  54. LePure Biotech
  55. Lonza
  56. Manipal Pharma Pack
  57. Marchesini
  58. MedCision
  59. MedicoPack
  60. Merck
  61. Momentive Technologies
  62. Muller2
  63. Nelson Labs
  64. Nemera
  65. Ningbo Zhengli Pharmaceutical Packaging
  66. Nipro
  67. OMRON Industrial Automation
  68. Origin Pharma Packaging
  69. Ott
  70. Pacific Vial
  71. Pall Corporation
  72. Pfeiffer Vacuum
  73. Pfizer
  74. Prince Sterilization Services
  75. Qingdao Huaren Medical Product
  76. Radpharm Scientific
  77. Raja Tradelinks
  78. Sagar Rubber
  79. Saint-Gobain
  80. Samsung Medical Rubber
  81. Savillex
  82. SCHOTT
  83. SCHOTT KAISHA
  84. Seiko Epson
  85. Serum Institute of India
  86. SGD Pharma
  87. Shandong Pharmaceutical Glass
  88. Sharp Global
  89. Single Use Support
  90. SiO2 Materials Science
  91. Sonata Rubber
  92. Stäubli
  93. Steriline
  94. Sterisets
  95. Stevanato
  96. SureCare
  97. SVM Automatik
  98. Swissfillon
  99. Syntegon
  100. TekPak Solutions
  101. Terumo Medical
  102. The State of Telangana
  103. Toxikon
  104. Transcoject
  105. Triveni Polymers
  106. Tyndall National Institute
  107. Universal Medicap
  108. Universal Robots
  109. Universal Protective Packaging
  110. Vaccines Manufacturing and Innovation Centre
  111. Vanrx Pharmasystems (a part of Cytiva)
  112. Vetter Pharm
  113. Vighnesh Rubbers
  114. W. L. Gore & Associates
  115. West Pharmaceutical Services
  116. Wheaton Industries
  117. Wirthwein Medical
  118. YangZhong Wealth Metal
  119. Yantai Xinhui Packing (acquired by Datwyler)
  120. YASWAKA
  121. Ypsomed

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com